Abstract
Objective: To assess the value of serum LH measurements in early- and late-follicular phase as predictors of ovarian response and IVF outcome in patients treated with recombinant FSH under GnRH-agonist pituitary down regulation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
